Novavax NVAX Stock
Novavax Price Chart
Novavax NVAX Financial and Trading Overview
| Novavax stock price | 5.98 USD |
| Previous Close | 7.72 USD |
| Open | 7.72 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1200 |
| Day's Range | 7.65 - 8.4 USD |
| 52 Week Range | 5.61 - 76.77 USD |
| Volume | 5.96M USD |
| Avg. Volume | 5.78M USD |
| Market Cap | 695.62M USD |
| Beta (5Y Monthly) | 1.711267 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.23 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22 USD |
NVAX Valuation Measures
| Enterprise Value | 287.89M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.409396 |
| PEG Ratio (5 yr expected) | 0.05 |
| Price/Sales (ttm) | 0.5119168 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.212 |
| Enterprise Value/EBITDA | -0.254 |
Trading Information
Novavax Stock Price History
| Beta (5Y Monthly) | 1.711267 |
| 52-Week Change | -79.97% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 76.77 USD |
| 52 Week Low | 5.61 USD |
| 50-Day Moving Average | 7.99 USD |
| 200-Day Moving Average | 13.64 USD |
NVAX Share Statistics
| Avg. Volume (3 month) | 5.78M USD |
| Avg. Daily Volume (10-Days) | 5.71M USD |
| Shares Outstanding | 86.31M |
| Float | 81.46M |
| Short Ratio | 4.64 |
| % Held by Insiders | 0.44% |
| % Held by Institutions | 61.53% |
| Shares Short | 30.03M |
| Short % of Float | 45.20% |
| Short % of Shares Outstanding | 34.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -85.016% |
| Operating Margin (ttm) | -85.86% |
| Gross Margin | -48.68% |
| EBITDA Margin | -83.56% |
Management Effectiveness
| Return on Assets (ttm) | -33.31% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.36B USD |
| Revenue Per Share (ttm) | 16.86 USD |
| Quarterly Revenue Growth (yoy) | -88.50% |
| Gross Profit (ttm) | -156045000 USD |
| EBITDA | -1135463936 USD |
| Net Income Avi to Common (ttm) | -1155251968 USD |
| Diluted EPS (ttm) | -13.91 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 624.95M USD |
| Total Cash Per Share (mrq) | 7.24 USD |
| Total Debt (mrq) | 246.57M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.506 |
| Book Value Per Share (mrq) | -10.379 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -653020032 USD |
| Levered Free Cash Flow (ttm) | -124903504 USD |
Profile of Novavax
| Country | United States |
| State | MD |
| City | Gaithersburg |
| Address | 21 Firstfield Road |
| ZIP | 20878 |
| Phone | 240 268 2000 |
| Website | https://www.novavax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1992 |
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Q&A For Novavax Stock
What is a current NVAX stock price?
Novavax NVAX stock price today per share is 5.98 USD.
How to purchase Novavax stock?
You can buy NVAX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novavax?
The stock symbol or ticker of Novavax is NVAX.
Which industry does the Novavax company belong to?
The Novavax industry is Biotechnology.
How many shares does Novavax have in circulation?
The max supply of Novavax shares is 160.84M.
What is Novavax Price to Earnings Ratio (PE Ratio)?
Novavax PE Ratio is now.
What was Novavax earnings per share over the trailing 12 months (TTM)?
Novavax EPS is -1.23 USD over the trailing 12 months.
Which sector does the Novavax company belong to?
The Novavax sector is Healthcare.
Novavax NVAX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17601.05 USD — |
+0.87
|
8.38B USD — | 17181.27 USD — | 17716.52 USD — | — - | 8.38B USD — |
| Dow Jones U.S. Biotechnology In DJUSBT | 2708.24 USD — |
+0.82
|
112.97M USD — | 2663.9 USD — | 2708.65 USD — | — - | 112.97M USD — |
| NASDAQ Composite Total Return I XCMP | 21542.13 USD — |
+0.87
|
— — | 21028.39 USD — | 21683.46 USD — | — - | — — |
| Nasdaq Next Generation 100 Inde NGX | 1190.09 USD — |
+1.39
|
— — | 1160.42 USD — | 1194.59 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4209.36 USD — |
+1.85
|
— — | 4100.47 USD — | 4211.44 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 942.47 USD — |
+1.43
|
— — | 920.56 USD — | 943.62 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4554.45 USD — |
+1.85
|
— — | 4436.63 USD — | 4556.71 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8613.57 USD — |
+0.85
|
— — | 8409.7 USD — | 8670.37 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4486.38 USD — |
-0.37
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}